OrganoStemTech: revolutionizing disease research and drug discovery, organoids and organ-on-chip technologies for precise and human-relevant results

We present another company newly arrived in the Avepark community: OrganoStemTech Lda., a biotechnology startup developing innovative solutions based on pluripotent stem cells and advanced 3D cellular models, with a focus on biomedical research and drug discovery.

Its solutions include organoids and microfluidic systems, such as organ-on-chip, enabling more precise and human-relevant disease modelling and drug response assessment, aligned with the trends of personalized medicine and preclinical innovation.